European Primary Care Cardiovascular Society

Characteristics, treatment and outcomes of contemporary AF patients in West-Europe

Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry

Literature - Erküner Ö, van Eck M, Xhaet O, et al., - Neth Heart J 2021,

Introduction and methods

Aim of the study

Registries are used to examine characteristics, treatment and outcomes of contemporary patients with atrial fibrillation (AF). Also, using data of registries, guideline adherence can be studied and awareness can be raised to improve treatment of AF patients. In this study, these aspects were examined in patients from the EURObservational Research Programme on Atrial Fibrillation long-term general (EORP-AF LTG) registry included in the Netherlands and Belgium.

Study design

The EORP-AF LTG registry is conducted in 27 countries and includes 11,096 patients from 2013 to 2016. For this analysis, 967 patients from the Netherlands and Belgium were included. Baseline characteristics and 1-year follow-up data were reported.


MACCE was defined as a composite of CV death, ischemic stroke/transient ischemic attach (TIA), systemic thromboembolism, myocardial infarction and major bleeding. AF progression was defined as paroxysmal AF at baseline becoming persistent/permanent AF at follow-up, whereas AF regression was defined as persistent/permanent AF at baseline becoming paroxysmal AF at follow-up.

Main results

Baseline characteristics

Rate vs. rhythm control therapy

Anticoagulant therapy


Rhythm follow-up and interventions


This analysis of the EORP-AF LTG registry showed the characteristics, treatment and outcomes of contemporary AF patients in Belgium and the Netherlands. The most common comorbidity was hypertension. Almost 17% of patients was incorrectly dosed for a NOAC. And MACCE occurred at a rate of 4.2% after 1 year, which is relatively low.

Find this article online at Neth Heart J

Share this page with your colleagues and friends: